Trials / Completed
CompletedNCT02978872
Quantra Determination of Coagulation Parameters in Arterial and Venous Blood
Comparison of Coagulation Parameters in Arterial and Venous Blood Measured Using the Quantra System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- HemoSonics LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Quantra™ System is a novel point-of-care diagnostic device designed to perform whole blood coagulation analysis. This study compares Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.
Detailed description
The Quantra System is a fully integrated and automated in vitro diagnostic device which utilizes SEER Sonorheometry, an ultrasound-based technology, to characterize the dynamic changes in the viscoelastic properties of a blood sample during coagulation and clot lysis. Viscoelastic testing performed using existing technologies is typically performed on arterial samples obtained from patients undergoing surgical procedures, although reference ranges for these tests have been established for venous blood only. The aim of this study is to evaluate potential differences between Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.
Conditions
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-12-01
- Last updated
- 2017-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02978872. Inclusion in this directory is not an endorsement.